101 related articles for article (PubMed ID: 15189359)
21. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
[TBL] [Abstract][Full Text] [Related]
22. Activation of the Wnt/β-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice.
Chen Y; Guan Y; Liu H; Wu X; Yu L; Wang S; Zhao C; Du H; Wang X
Biochem Biophys Res Commun; 2012 Apr; 420(2):397-403. PubMed ID: 22426476
[TBL] [Abstract][Full Text] [Related]
23. Assessing the role of immuno-proteasomes in a mouse model of familial ALS.
Puttaparthi K; Van Kaer L; Elliott JL
Exp Neurol; 2007 Jul; 206(1):53-8. PubMed ID: 17482163
[TBL] [Abstract][Full Text] [Related]
24. Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis.
Kiaei M; Kipiani K; Chen J; Calingasan NY; Beal MF
Exp Neurol; 2005 Feb; 191(2):331-6. PubMed ID: 15649489
[TBL] [Abstract][Full Text] [Related]
25. Dissociation between neurodegeneration and caspase-11-mediated activation of caspase-1 and caspase-3 in a mouse model of amyotrophic lateral sclerosis.
Kang SJ; Sanchez I; Jing N; Yuan J
J Neurosci; 2003 Jul; 23(13):5455-60. PubMed ID: 12843244
[TBL] [Abstract][Full Text] [Related]
26. Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis pain.
Sagar DR; Staniaszek LE; Okine BN; Woodhams S; Norris LM; Pearson RG; Garle MJ; Alexander SP; Bennett AJ; Barrett DA; Kendall DA; Scammell BE; Chapman V
Arthritis Rheum; 2010 Dec; 62(12):3666-76. PubMed ID: 20722027
[TBL] [Abstract][Full Text] [Related]
27. Non-neuronal induction of immunoproteasome subunits in an ALS model: possible mediation by cytokines.
Puttaparthi K; Elliott JL
Exp Neurol; 2005 Dec; 196(2):441-51. PubMed ID: 16242125
[TBL] [Abstract][Full Text] [Related]
28. Finding of endocannabinoids in human eye tissues: implications for glaucoma.
Chen J; Matias I; Dinh T; Lu T; Venezia S; Nieves A; Woodward DF; Di Marzo V
Biochem Biophys Res Commun; 2005 May; 330(4):1062-7. PubMed ID: 15823551
[TBL] [Abstract][Full Text] [Related]
29. Neuroprotective effects of diallyl trisulfide in SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis.
Guo Y; Zhang K; Wang Q; Li Z; Yin Y; Xu Q; Duan W; Li C
Brain Res; 2011 Feb; 1374():110-5. PubMed ID: 21147075
[TBL] [Abstract][Full Text] [Related]
30. A mouse model of familial ALS has increased CNS levels of endogenous ubiquinol9/10 and does not benefit from exogenous administration of ubiquinol10.
Lucchetti J; Marino M; Papa S; Tortarolo M; Guiso G; Pozzi S; Bonetto V; Caccia S; Beghi E; Bendotti C; Gobbi M
PLoS One; 2013; 8(7):e69540. PubMed ID: 23936040
[TBL] [Abstract][Full Text] [Related]
31. Increase of disease duration of amyotrophic lateral sclerosis in a mouse model by transgenic small interfering RNA.
Yokota T; Sasaguri H; Saito Y; Yamada H; Unno T; Yamamoto Y; Kubodera T; Anzai M; Mitani T; Mizusawa H
Arch Neurol; 2007 Jan; 64(1):145-6. PubMed ID: 17210827
[No Abstract] [Full Text] [Related]
32. Endocannabinoids control spasticity in a multiple sclerosis model.
Baker D; Pryce G; Croxford JL; Brown P; Pertwee RG; Makriyannis A; Khanolkar A; Layward L; Fezza F; Bisogno T; Di Marzo V
FASEB J; 2001 Feb; 15(2):300-2. PubMed ID: 11156943
[TBL] [Abstract][Full Text] [Related]
33. MMP-2 and MMP-9 are elevated in spinal cord and skin in a mouse model of ALS.
Fang L; Teuchert M; Huber-Abel F; Schattauer D; Hendrich C; Dorst J; Zettlmeissel H; Wlaschek M; Scharffetter-Kochanek K; Kapfer T; Tumani H; Ludolph AC; Brettschneider J
J Neurol Sci; 2010 Jul; 294(1-2):51-6. PubMed ID: 20441996
[TBL] [Abstract][Full Text] [Related]
34. The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis.
Centonze D; Bari M; Rossi S; Prosperetti C; Furlan R; Fezza F; De Chiara V; Battistini L; Bernardi G; Bernardini S; Martino G; Maccarrone M
Brain; 2007 Oct; 130(Pt 10):2543-53. PubMed ID: 17626034
[TBL] [Abstract][Full Text] [Related]
35. miRNA-9 expression is upregulated in the spinal cord of G93A-SOD1 transgenic mice.
Zhou F; Guan Y; Chen Y; Zhang C; Yu L; Gao H; Du H; Liu B; Wang X
Int J Clin Exp Pathol; 2013; 6(9):1826-38. PubMed ID: 24040447
[TBL] [Abstract][Full Text] [Related]
36. Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders.
Espejo-Porras F; Piscitelli F; Verde R; Ramos JA; Di Marzo V; de Lago E; Fernández-Ruiz J
J Neuroimmune Pharmacol; 2015 Jun; 10(2):233-44. PubMed ID: 25819934
[TBL] [Abstract][Full Text] [Related]
37. Message and protein-level elevation of tumor necrosis factor alpha (TNF alpha) and TNF alpha-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis.
Hensley K; Fedynyshyn J; Ferrell S; Floyd RA; Gordon B; Grammas P; Hamdheydari L; Mhatre M; Mou S; Pye QN; Stewart C; West M; West S; Williamson KS
Neurobiol Dis; 2003 Oct; 14(1):74-80. PubMed ID: 13678668
[TBL] [Abstract][Full Text] [Related]
38. Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids.
Luchicchi A; Pistis M
Mol Neurobiol; 2012 Oct; 46(2):374-92. PubMed ID: 22801993
[TBL] [Abstract][Full Text] [Related]
39. Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS.
Lepore AC; Haenggeli C; Gasmi M; Bishop KM; Bartus RT; Maragakis NJ; Rothstein JD
Brain Res; 2007 Dec; 1185():256-65. PubMed ID: 17963733
[TBL] [Abstract][Full Text] [Related]
40. Endogenous cannabinoids: structure and metabolism.
Bisogno T
J Neuroendocrinol; 2008 May; 20 Suppl 1():1-9. PubMed ID: 18426492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
